Ajanta Pharma | inves4: Investing, News, Financial Planning

Awards and Recognitions (0)

Key Decisions by Management (0)

Promises/ Predictions by Management (0)

Key financial Decisions (0)

Accounting Observations (0)

Regulatory Actions (0)

Legal Cases (0)

Shareholders Activism (0)

Key Employee Resignations/ Hirings (0)

Customer Feedback (0)

Product/ Service Quality (0)

New Business/ Tie-Ups (0)

Discontinued Businesses (0)

Mergers/ Acquisitions (0)

Restructuring (0)

Fund Raises (0)

Shareholding Changes (0)

Employee Feedback (0)

Views by Analysts/ Investors (0)

Share Picks by Veterans (0)

Interesting Facts (0)

Important News (0)

Ajanta in keeping with the tradition announces one more buyback

March 10, 2023

Ajanta Pharma has announced buyback once more. This is 4th year in a row, previous 3 details can be checked here. Current buyback details are – 22,10,500 shares constituting 1.73% ... Read more

Ajanta Promoters sell some stake. Continue to retain significant.

December 22, 2022

Ajanta Pharma has informed that two of it’s prom0ter entities have sold stake totalling 4.38% into the Company through open market transactions. Total Promoter stake consequently has reduced from 70.48% ... Read more

India's Best Managed Companies 2022 Winners - Deloitte

October 15, 2022

Deloitte has declared the winners of India’s Best Managed Companies Programme (BMCP) 2022. Ajanta Pharma Limited Coromandel International Limited Crompton Greaves Consumer Electricals Limited Dabur India Limited Endurance Technologies Limited ... Read more

Ajanta Pharma decides to buyback again

December 23, 2021

The Company’s board is scheduled to meet on December 28, 2021 to take the decision. Key points to note – This is 3rd year in a row. Previous ones being ... Read more

Do you have something important to share about the Company?

0 Comments

Inline Feedbacks

View all comments